文献速递认知障碍与痴呆

与阿尔茨海默病病理相关的词汇和声学言语特征

Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology.
PubMed 文献 · Neurology · 2022-07-25

该横断面研究比较了生物学确认的遗忘型阿尔茨海默病(aAD)与logopenic变异型原发性进行性失语(lvPPA)患者的数字言语和语言特征,并与健康对照比较,同时分析这些特征与神经心理测验评分及脑脊液磷酸化tau水平的相关性。研究发现lvPPA患者较aAD患者产出更少动词和形容词、更多填充词、更低词汇多样性和更高停顿率,部分言语特征与MMSE、波士顿命名测验评分及脑脊液p-tau水平相关。

要点

  • lvPPA患者较aAD患者动词更少(10.5±2.3 vs 12.5±2,p=0.001)、形容词更少(2.7±1.3 vs 3.8±2,p=0.019)、填充词更多(7.4±3.9 vs 4.9±4.5,p=0.022)。
  • lvPPA患者较aAD患者词汇多样性更低(0.84±0.1 vs 0.87±0.1,p=0.05)、停顿率更高(54.2±19.2 vs 45.3±12.8,p=0.015)。
  • 词频、副词、停顿率和词长与MMSE及BNT评分显著相关,介词、名词、言语片段时长、词频和停顿率与脑脊液p-tau水平相关。

核心结论

  • 自动化言语测量可捕捉传统语言临床评估未能识别的aAD与lvPPA两种表型间的语言和言语差异。
  • 自然言语有潜力反映阿尔茨海默病病理相关的潜在变异型。

研究设计与样本

  • 横断面研究,纳入美国宾夕法尼亚大学额颞叶变性中心招募的aAD患者44例、lvPPA患者21例和年龄匹配的健康对照28例。
  • aAD和lvPPA患者经脑脊液(p-tau/Aβ≥0.09且总tau/Aβ≥0.34)或尸检确认阿尔茨海默病病理。
  • 从受试者口头图片描述中通过自动化词汇和声学流程提取言语和语言变量。

主要发现

  • lvPPA组动词10.5±2.3 vs aAD组12.5±2(p=0.001),lvPPA组更少。
  • lvPPA组形容词2.7±1.3 vs aAD组3.8±2(p=0.019),lvPPA组更少。
  • lvPPA组填充词7.4±3.9 vs aAD组4.9±4.5(p=0.022),lvPPA组更多。
  • lvPPA组词汇多样性0.84±0.1 vs aAD组0.87±0.1(p=0.05),lvPPA组更低;lvPPA组停顿率54.2±19.2 vs aAD组45.3±12.8(p=0.015),lvPPA组更高。
  • 词频(MMSE β=-1.6,p=0.009;BNT β=-4.36,p<0.001)、副词(MMSE β=-1.9,p=0.003;BNT β=-2.41,p=0.041)、停顿率(MMSE β=-1.21,p=0.041;BNT β=-2.09,p=0.041)和词长(MMSE β=1.75,p=0.001;BNT β=2.94,p=0.003)与MMSE和BNT评分显著相关;介词(r=-0.36,p=0.019)、名词(r=-0.31,p=0.047)、言语片段时长(r=-0.33,p=0.032)、词频(r=0.33,p=0.036)和停顿率(r=0.34,p=0.026)与脑脊液p-tau水平相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: We compared digital speech and language features of patients with amnestic Alzheimer disease (aAD) or logopenic variant primary progressive aphasia (lvPPA) in a biologically confirmed cohort and related these features to neuropsychiatric test scores and CSF analytes. METHODS: We included patients with aAD or lvPPA with CSF (phosphorylated tau ([p-tau]/β-amyloid [Aβ] ≥0.09, and total tau/Aβ ≥0.34) or autopsy confirmation of AD pathology and age-matched healthy controls (HC) recruited at the Frontotemporal Degeneration Center of the University of Pennsylvania for a cross-sectional study. We extracted speech and language variables with automated lexical and acoustic pipelines from participants' oral picture descriptions. We compared the groups and correlated distinct features with clinical ratings and CSF p-tau levels. RESULTS: We examined patients with aAD (n = 44; age 62 ± 8 years; 24 women; Mini-Mental State Examination [MMSE] score 21.1 ± 4.8) or lvPPA (n = 21; age 64.1 ± 8.2 years; 11 women; MMSE score 23.0 ± 4.2) and HC (n = 28; age 65.9 ± 5.9 years, 15 women; MMSE score 29 ± 1). Patients with lvPPA produced fewer verbs (10.5 ± 2.3; p = 0.001) and adjectives (2.7 ± 1.3, p = 0.019) and more fillers (7.4 ± 3.9; p = 0.022) with lower lexical diversity (0.84 ± 0.1; p = 0.05) and higher pause rate (54.2 ± 19.2; p = 0.015) than individuals with aAD (verbs 12.5 ± 2; adjectives 3.8 ± 2; fillers 4.9 ± 4.5; lexical diversity 0.87 ± 0.1; pause rate 45.3 ± 12.8). Both groups showed some shared language impairments compared with HC. Word frequency (MMSE score: β = -1.6, p = 0.009; Boston Naming Test [BNT] score: β = -4.36, p < 0.001), adverbs (MMSE score: β = -1.9, p = 0.003; BNT score: β = -2.41, p = 0.041), pause rate (MMSE score: β = -1.21, p = 0.041; BNT score: β = -2.09, p = 0.041), and word length (MMSE score: β = 1.75, p = 0.001; BNT score: β = 2.94, p = 0.003) were significantly correlated with both MMSE and BNT scores, but other measures were not correlated with MMSE and/or BNT score. Prepositions (r = -0.36, p = 0.019), nouns (r = -0.31, p = 0.047), speech segment duration (r = -0.33, p = 0.032), word frequency (r = 0.33, p = 0.036), and pause rate (r = 0.34, p = 0.026) were correlated with patients' CSF p-tau levels. DISCUSSION: Our measures captured language and speech differences between the 2 phenotypes that traditional language-based clinical assessments failed to identify. This work demonstrates the potential of natural speech in reflecting underlying variants with AD pathology.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Cho S, Cousins KAQ, Shellikeri S, et al. Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology. Neurology. 2022. PMID: 35487701. doi:10.1212/WNL.0000000000200581

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。